Drug Database
MI

mixed amphetamine salts extended release (Adderall XR / Adderall, Microtrol / MAS XR)

✓ Approved

Shire · SLC18A2 · Small Molecule

What is mixed amphetamine salts extended release?

mixed amphetamine salts extended release is a small molecule developed by Shire. It is approved for therapeutic indications via oral (po).

Drug Profile

Brand NamesAdderall XR, Adderall, Microtrol, MAS XR
CompanyShire
Drug ClassSmall Molecule
Molecular TargetSLC18A2
RouteOral (PO)
StatusApproved

Mechanism of Action

Molecular Targets

mixed amphetamine salts extended release acts on 1 molecular target:

SLC18A2solute carrier family 18 member A2 (SVMT, VAT2)
Want deeper analysis?Noah AI can explain complex mechanisms and compare to similar drugs.

Therapeutic Indications

mixed amphetamine salts extended release is developed for 1 unique indication across 1 therapeutic area.

Therapeutic AreaConditionPhase
Psychiatric disordersAttention deficit hyperactivity disorder✓ Approved

Related Research Articles

PubMedBiochimie2026-05-24

Mapping Hofmeister Cation and Anion Effects on Seeded and Unseeded Aggregation of TDP-43 and Amyloid-β in Micelle-Assisted Seed Amplification.

Yamahara Naoki N, Nakanishi Yusuke Y, Tahara Akuto A, Inden Masatoshi M et al.

Seed-amplification assays (SAA) amplify trace protein aggregates and are being developed for early diagnosis of neurodegenerative diseases. We previously demonstrated that the addition of Brij-58 micelles markedly increases the sensitivity of TDP-43 and Aβ SAA by 100-1000-fold, and established micelle-assisted SAA (mSAA). Here we map Hofmeister cation and anion effects on the aggregation of TDP-43(267-414) and Aβ(M1-42) in mSAA using 15 salts. For TDP-43, kosmotropic anions promoted aggregation whereas chaotropic anions inhibited it; cation trends were weaker and substrate-dependent. By contrast, all salts accelerated Aβ aggregation, with Mg2+ and Ca2+ producing the largest effects. In most cases, seeded and unseeded kinetics shifted in parallel; notably, low guanidinium chloride (110-220 mM) preferentially suppressed seed-independent TDP-43 aggregation, thereby improving seed discrimination. These ion-specific behaviors can be interpreted within a protein-decorated micelle working model in which Aβ aggregation is governed primarily by electrostatic screening, whereas TDP-43 aggregation reflects specific-ion-mediated dehydration of micelles and protein surfaces.

PubMedFood chemistry2026-05-24

Structure-property evolution of insoluble dietary fiber from wheat bran under solid-state fermentation and its effect on functional and processing properties.

Liang Wei W, Lin Qian Q, Xiong Ke K, Li Wenhao W

This study investigated the role of co-fermentation in converting wheat bran biomass by characterizing insoluble dietary fiber (IDF) extracted at different stages (12, 24, 48 h) of fermentation with various strains (Control, NF, YF, LF, MF). Microscopic observations (SEM, CLSM) showed that fermentation caused IDF structural breakdown, particle size reduction, and honeycomb-like porous morphology. FT-IR and XRD verified structural degradation and increased molecular disorder. These changes enhanced thermal stability, water retention, and oxygen vacancy intensity, with particle size reduced. The porous structure improved physicochemical and functional properties, promoted phenolic release, and strengthened antioxidant activity. The mixed fermentation (MF) group exhibited the most significant degradation and superior structural and functional properties compared with single strains. These findings provide a feasible approach for high-value utilization of wheat bran biomass.

PubMedOrganic letters2026-05-24

Pyridinium Design for Deaminative Reactions of Sterically Encumbered Alkyl Amines.

Enudi Obieze C OC, Twitty J Cameron JC, Rotella Madeline E ME, Underwood Steven J SJ et al.

We introduce a new 3,5-diphenylpyridinium motif that can be readily installed on α-tertiary alkyl amines and enables effective deamination. This advance overcomes the limitation that Katritzky pyridinium salts cannot be accessed from α-tertiary alkyl amines. Use of this 3,5-diphenylpyridinium salt enables a nickel-catalyzed reductive alkylation of Michael acceptors to construct quaternary carbons with a broad range of tertiary alkyl groups. Density functional theory (DFT) calculations were used to understand the surprising reactivity difference between adamantyl and other tertiary alkyl groups.

PubMedInternational journal of speech-language pathology2026-05-24

Using mixed methods research to guide evidence-based practice in speech-language pathology interventions.

Hryciw Tegan T, Charest Monique M, Filiatrault-Veilleux Pamela P

The practice of speech-language pathology, guided by evidence-based practice, relies on high-quality research evidence to support clinical decision-making. Mixed methods research designs, which collect and integrate both quantitative and qualitative data in order to achieve a deep understanding of a phenomenon, have been presented as a way to produce research that is relevant to the complex practice settings of speech-language pathologists. This paper aims to demonstrate the utility of mixed methods intervention research to support clinical decision-making in speech-language pathology practice. Part one provides a description of mixed methods research including its core features, design types, and indicators of quality. Part two discusses theoretical underpinnings of quantitative and qualitative approaches, and explain paradigms or theoretical stances relevant to the interpretation of mixed methods research. An understanding of mixed methods research can contribute to evidence-based practice in speech-language pathology practice, and can help clinicians to provide services that are person-centred and sensitive to sociocultural and contextual factors.

PubMedJournal of microencapsulation2026-05-24

Granulation-driven modulation of improved advanced flow properties with immediate drug release using modified Eudragit EPO granules.

Chilbule Yogesh Y, Karanwad Tukaram T, Banerjee Subham S

This study aimed to improve the flowability and manufacturability of cohesive Eudragit EPO using wet granulation for immediate-release tablet formulations. rPowder flow properties were evaluated using conventional micromeritic methods and advanced rheological analysis with a Brookfield Powder Flow Tester. Wet granulation was performed using 0.25% w/w hydroxypropyl methylcellulose, with and without isoniazid as a model drug. Granules and tablets were characterised for particle properties, solid-state behaviour, physicomechanical characteristics, and drug release. Raw Eudragit EPO exhibited poor flowability and high cohesiveness. Wet granulation significantly improved flow properties, increased particle size, and reduced surface area. Tablets prepared from optimised granules showed acceptable hardness, friability, disintegration, content uniformity, and complete drug release within 2 h in 0.1 N HCl. Solid-state analyses confirmed chemical compatibility and partial amorphization without degradation. Wet granulation effectively transformed Eudragit EPO into a free-flowing and compressible material suitable for immediate-release tablet manufacturing.

PubMedPediatric transplantation2026-05-24

Dosing, Safety, and Tolerability of Extended-Release Tacrolimus in Pediatric and Young Adult Solid Organ Transplant Recipients.

Dang Terry T, Hewlett Jennifer J, McAteer John J, Downes Kevin J KJ

Complicated immunosuppression regimens can contribute to non-adherence in pediatric solid organ transplant (SOT) recipients. Once-daily tacrolimus formulations, such as LCP-tacrolimus (LCPT), may help simplify dosing, but pediatric data on dosing, safety, and early tolerability are limited. We conducted a single center retrospective cohort study of SOT recipients prescribed LCPT from December 2016 to July 2024 at our institution. LCPT:IR-Tac daily dosing ratios were calculated. The frequency of laboratory-associated adverse events (AE) and of new patient-reported adverse events in the first 90 days were collected and compared across pediatric- and adult-aged SOT recipients. Ninety-one SOT recipients were prescribed LCPT at a median age of 16.8 years (range 8.4-24.1) and 75 months after transplant (range 0.25-217). Among 53 patients who were therapeutic on both IR-Tac and LCPT, the median daily dosing ratio of LCPT:IR-Tac was 0.75 (range 0.33-1.5) for pediatric patients and 0.75 (IQR: 0.46-1.33) for adults. Eleven (5 patient-reported and 6 laboratory) AEs were identified, none of which resulted in cessation of LCPT therapy. There were no significant differences in the frequency of AEs between children and adults. LCPT was well tolerated and typically required about a 25% dose reduction compared with IR-tacrolimus, though conversion ratios varied widely. These findings offer practical guidance for LCPT dosing in pediatric transplant care and highlight the need for individualized titration and monitoring.

+9996 more articles available with a free account

Sign up free to view all articles →

Ask about mixed amphetamine salts extended release